Cross Border
-
Ferrari at the crossroads, but it should get back on track
Fiat has already benefited from spinning off its most valuable brand, but can the legendary Italian sports car company find a new gear on its own?
-
How Divesh Makan gained entry into Zuckerberg's inner circle
Not all financial advisors are created equal. Meet Divesh Makan, consigliere to Silicon Valley's brightest billionaires
-
A startup of ex-Googlers is reinventing the telephone
Google has a new secret weapon in its fight against Microsoft Office
-
My weaknesses died on that day: Malala
Four months before she won the Nobel Peace Prize, Forbes brought teenage Pakistani education activist Malala Yousafzai to our Third Annual Summit on Philanthropy, held in June. Laurene Powell Jobs, an education and immigration advocate and the widow of Apple co-founder Steve Jobs, interviewed Malala before an audience of nearly 200 leading philanthropists
-
Cargill too central to global agribusiness to falter
In an exclusive interview Cargill's new CEO, David MacLennan, outlines his plans to make the world's biggest agribusiness bigger. Not that it needs help
-
The world's most powerful people
Power has been called many things. Pretty isn't one of them.
-
WeWork: The leader in shared working space movement
WeWork has emerged as one of the most valuable startups in America by combining the savvy of a real estate developer with the soul of a Kibbutz
-
Taser aspires to be the Dropbox for cops
Rick Smith's company is now looking at body cams and digital video storage in defence
-
Battle-scarred billionaire Jeffrey Gundlach is ready to be coronated
Bill Gross' spectacular fall from the top of the bond market has put tens of billions in play at a time when minuscule yields demand a fixed-income superstar. A brilliant, battlescarred billionaire, Jeffrey Gundlach, stands ready to be coronated
-
Munchery believes the evening meal is best served cold
Munchery hopes stone-cold logistics will help it win the war over the evening meal
-
America's 50 Best small Companies
Technology and health care firms dominate Forbes' list of the fastest growing public companies with sales under $1 billion